Accelerating clinical trials in the EU: for better clinical trials that address patients’ need

EMA

13 January 2022 - Today, the European Commission, the Heads of Medicines Agencies and the EMA have launched an initiative to transform how clinical trials are initiated, designed and run, referred to as Accelerating Clinical Trials in the EU. 

The aim is to further develop the EU as a focal point for clinical research, further promote the development of high quality, safe and effective medicines, and to better integrate clinical research in the European health system.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder